Logo image of SEAT

VIVID SEATS INC - CLASS A (SEAT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SEAT - US92854T2096 - Common Stock

6.89 USD
+0.38 (+5.84%)
Last: 1/16/2026, 8:00:02 PM
6.89 USD
0 (0%)
After Hours: 1/16/2026, 8:00:02 PM
Fundamental Rating

1

Taking everything into account, SEAT scores 1 out of 10 in our fundamental rating. SEAT was compared to 80 industry peers in the Entertainment industry. SEAT may be in some trouble as it scores bad on both profitability and health. SEAT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • SEAT had positive earnings in the past year.
  • In the past year SEAT has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: SEAT reported negative net income in multiple years.
  • SEAT had a positive operating cash flow in 4 of the past 5 years.
SEAT Yearly Net Income VS EBIT VS OCF VS FCFSEAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -14.00%, SEAT is doing worse than 77.50% of the companies in the same industry.
  • SEAT has a worse Return On Equity (-56.96%) than 68.75% of its industry peers.
Industry RankSector Rank
ROA -14%
ROE -56.96%
ROIC N/A
ROA(3y)2.63%
ROA(5y)-11.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SEAT Yearly ROA, ROE, ROICSEAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

  • SEAT's Operating Margin has declined in the last couple of years.
  • SEAT has a better Gross Margin (71.45%) than 80.00% of its industry peers.
  • SEAT's Gross Margin has been stable in the last couple of years.
  • SEAT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.45%
OM growth 3Y-31.94%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.39%
GM growth 5Y-0.9%
SEAT Yearly Profit, Operating, Gross MarginsSEAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

0

2. Health

2.1 Basic Checks

  • SEAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SEAT has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SEAT has more shares outstanding
  • Compared to 1 year ago, SEAT has a worse debt to assets ratio.
SEAT Yearly Shares OutstandingSEAT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
SEAT Yearly Total Debt VS Total AssetsSEAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • SEAT has an Altman-Z score of -0.97. This is a bad value and indicates that SEAT is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -0.97, SEAT is not doing good in the industry: 71.25% of the companies in the same industry are doing better.
  • SEAT has a Debt/Equity ratio of 1.41. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.41, SEAT is not doing good in the industry: 72.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.41
Debt/FCF N/A
Altman-Z -0.97
ROIC/WACCN/A
WACC6.72%
SEAT Yearly LT Debt VS Equity VS FCFSEAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M

2.3 Liquidity

  • A Current Ratio of 0.67 indicates that SEAT may have some problems paying its short term obligations.
  • SEAT has a Current ratio of 0.67. This is in the lower half of the industry: SEAT underperforms 70.00% of its industry peers.
  • SEAT has a Quick Ratio of 0.67. This is a bad value and indicates that SEAT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SEAT has a worse Quick ratio (0.60) than 71.25% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.6
SEAT Yearly Current Assets VS Current LiabilitesSEAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

1

3. Growth

3.1 Past

  • SEAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.50%.
  • The Revenue for SEAT has decreased by -16.83% in the past year. This is quite bad
  • The Revenue has been growing by 10.59% on average over the past years. This is quite good.
EPS 1Y (TTM)-57.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-262.5%
Revenue 1Y (TTM)-16.83%
Revenue growth 3Y20.52%
Revenue growth 5Y10.59%
Sales Q2Q%-26.92%

3.2 Future

  • SEAT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -42.86% yearly.
  • Based on estimates for the next years, SEAT will show a decrease in Revenue. The Revenue will decrease by -3.64% on average per year.
EPS Next Y-1969.55%
EPS Next 2Y-132.21%
EPS Next 3Y-63.11%
EPS Next 5Y-42.86%
Revenue Next Year-24.63%
Revenue Next 2Y-19.54%
Revenue Next 3Y-10.84%
Revenue Next 5Y-3.64%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SEAT Yearly Revenue VS EstimatesSEAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
SEAT Yearly EPS VS EstimatesSEAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 10 -10 -20

3

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 5.07 indicates a rather cheap valuation of SEAT.
  • Based on the Price/Earnings ratio, SEAT is valued cheaply inside the industry as 96.25% of the companies are valued more expensively.
  • SEAT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.47.
  • The Forward Price/Earnings Ratio is negative for SEAT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 5.07
Fwd PE N/A
SEAT Price Earnings VS Forward Price EarningsSEAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

  • SEAT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SEAT is cheaper than 62.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.24
SEAT Per share dataSEAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

  • A cheap valuation may be justified as SEAT's earnings are expected to decrease with -63.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-132.21%
EPS Next 3Y-63.11%

0

5. Dividend

5.1 Amount

  • No dividends for SEAT!.
Industry RankSector Rank
Dividend Yield 0%

VIVID SEATS INC - CLASS A

NASDAQ:SEAT (1/16/2026, 8:00:02 PM)

After market: 6.89 0 (0%)

6.89

+0.38 (+5.84%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-06
Earnings (Next)03-10
Inst Owners45.62%
Inst Owner Change3.39%
Ins Owners4.88%
Ins Owner Change-36.07%
Market Cap73.93M
Revenue(TTM)643.77M
Net Income(TTM)-155.03M
Analysts69.41
Price Target26.82 (289.26%)
Short Float %13.29%
Short Ratio5.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)264.83%
Min EPS beat(2)-11.46%
Max EPS beat(2)541.12%
EPS beat(4)1
Avg EPS beat(4)-13.32%
Min EPS beat(4)-472.49%
Max EPS beat(4)541.12%
EPS beat(8)3
Avg EPS beat(8)-9.13%
EPS beat(12)7
Avg EPS beat(12)36.69%
EPS beat(16)10
Avg EPS beat(16)179.77%
Revenue beat(2)1
Avg Revenue beat(2)-2.83%
Min Revenue beat(2)-7.42%
Max Revenue beat(2)1.76%
Revenue beat(4)2
Avg Revenue beat(4)-2.51%
Min Revenue beat(4)-7.42%
Max Revenue beat(4)1.76%
Revenue beat(8)4
Avg Revenue beat(8)-0.31%
Revenue beat(12)8
Avg Revenue beat(12)3.66%
Revenue beat(16)12
Avg Revenue beat(16)6.11%
PT rev (1m)-2.05%
PT rev (3m)-31.79%
EPS NQ rev (1m)-2.78%
EPS NQ rev (3m)-81.92%
EPS NY rev (1m)2.68%
EPS NY rev (3m)-0.28%
Revenue NQ rev (1m)-0.62%
Revenue NQ rev (3m)-8.41%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-1.37%
Valuation
Industry RankSector Rank
PE 5.07
Fwd PE N/A
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.27
P/tB N/A
EV/EBITDA 21.24
EPS(TTM)1.36
EY19.74%
EPS(NY)-4.55
Fwd EYN/A
FCF(TTM)-1.23
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS60
BVpS25.36
TBVpS-52.72
PEG (NY)N/A
PEG (5Y)N/A
Graham Number27.86
Profitability
Industry RankSector Rank
ROA -14%
ROE -56.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.45%
FCFM N/A
ROA(3y)2.63%
ROA(5y)-11.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.08%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-31.94%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.39%
GM growth 5Y-0.9%
F-Score3
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 1.41
Debt/FCF N/A
Debt/EBITDA 26.08
Cap/Depr 14.99%
Cap/Sales 1.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.6
Altman-Z -0.97
F-Score3
WACC6.72%
ROIC/WACCN/A
Cap/Depr(3y)22.81%
Cap/Depr(5y)24.24%
Cap/Sales(3y)0.5%
Cap/Sales(5y)0.53%
Profit Quality(3y)249.59%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-262.5%
EPS Next Y-1969.55%
EPS Next 2Y-132.21%
EPS Next 3Y-63.11%
EPS Next 5Y-42.86%
Revenue 1Y (TTM)-16.83%
Revenue growth 3Y20.52%
Revenue growth 5Y10.59%
Sales Q2Q%-26.92%
Revenue Next Year-24.63%
Revenue Next 2Y-19.54%
Revenue Next 3Y-10.84%
Revenue Next 5Y-3.64%
EBIT growth 1Y-171.92%
EBIT growth 3Y-17.97%
EBIT growth 5YN/A
EBIT Next Year-11.56%
EBIT Next 3Y4.14%
EBIT Next 5Y11.28%
FCF growth 1Y-110.49%
FCF growth 3Y-34.7%
FCF growth 5Y-8.36%
OCF growth 1Y-104.4%
OCF growth 3Y-32.56%
OCF growth 5Y-6.76%

VIVID SEATS INC - CLASS A / SEAT FAQ

Can you provide the ChartMill fundamental rating for VIVID SEATS INC - CLASS A?

ChartMill assigns a fundamental rating of 1 / 10 to SEAT.


What is the valuation status for SEAT stock?

ChartMill assigns a valuation rating of 3 / 10 to VIVID SEATS INC - CLASS A (SEAT). This can be considered as Overvalued.


How profitable is VIVID SEATS INC - CLASS A (SEAT) stock?

VIVID SEATS INC - CLASS A (SEAT) has a profitability rating of 2 / 10.


Can you provide the financial health for SEAT stock?

The financial health rating of VIVID SEATS INC - CLASS A (SEAT) is 0 / 10.


What is the earnings growth outlook for VIVID SEATS INC - CLASS A?

The Earnings per Share (EPS) of VIVID SEATS INC - CLASS A (SEAT) is expected to decline by -1969.55% in the next year.